Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis-Reference-Cited by-同舟云学术

Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis

Published:2018-01-22 Issue:3 Volume:19 Page:188-197
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Garza-Morales Rodolfo¹²,Yaddanapudi Kavitha³,Perez-Hernandez Rigoberto¹,Riedinger Eric¹,McMasters Kelly M.¹³,Shirwan Haval⁴,Yolcu Esma⁴,Montes de Oca-Luna Roberto²,Gomez-Gutierrez Jorge G.¹³^ORCID

Affiliation:

1. The Hiram C. Polk Jr, MD, Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA

2. Department of Histology, School of Medicine, Autonomous University of Nuevo León, Monterrey, N.L. México

3. James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, USA

4. Department of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville, Louisville, KY, USA

Funder

HHS | NIH | National Cancer Institute (NCI)

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2017.1416274

Reference26 articles.

1. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer

2. Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors

3. Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice

4. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy

5. Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The investigation of oncolytic viruses in the field of cancer therapy;Frontiers in Oncology;2024-07-10

2. Correction;Cancer Biology & Therapy;2024-05-15

3. Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions;Frontiers in Oncology;2022-03-17

4. Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo;Cancers;2020-08-14

5. Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro;Cancers;2018-05-17